Zhao, SS;
Harrison, SR;
Chan, A;
Clarke, N;
Davis, C;
Eddison, J;
Gregory, WJ;
Jones, GT;
Marzo-Ortega, H;
Murphy, DJ;
et al.
Zhao, SS; Harrison, SR; Chan, A; Clarke, N; Davis, C; Eddison, J; Gregory, WJ; Jones, GT; Marzo-Ortega, H; Murphy, DJ; Sandhu, V; Sengupta, R; Siebert, S; Thompson, B; Webb, D; Yates, M; Gaffney, K
(2023)
Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope.
Rheumatol Adv Pract, 7 (2).
rkad039.
ISSN 2514-1775
https://doi.org/10.1093/rap/rkad039
SGUL Authors: Sandhu, Virinderjit
Abstract
Pharmacological management has advanced considerably since the 2015 British Society for Rheumatology axial spondyloarthritis (axSpA) guideline to incorporate new classes of biologic DMARDs (bDMARDs, including biosimilars), targeted synthetic DMARDs (tsDMARDs) and treatment strategies such as drug tapering. The aim of this guideline is to provide an evidence-based update on pharmacological management of adults with axSpA (including AS and non-radiographic axSpA) using b/tsDMARDs. This guideline is aimed at health-care professionals in the UK who care directly for people with axSpA, including rheumatologists, rheumatology specialist nurses, allied health professionals, rheumatology specialty trainees and pharmacists; people living with axSpA; and other stakeholders, such as patient organizations and charities.
| Item Type: |
Article
|
| Additional Information: |
© The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| Keywords: |
AS, Axial spondyloarthritis, IL17, JAK inhibitor, biologic, biosimilar, switching, tapering, treat-to-target, Axial spondyloarthritis, AS, biologic, biosimilar, IL17, JAK inhibitor, treat-to-target, switching, tapering |
| SGUL Research Institute / Research Centre: |
Academic Structure > Institute of Medical & Biomedical Education (IMBE) |
| Journal or Publication Title: |
Rheumatol Adv Pract |
| ISSN: |
2514-1775 |
| Language: |
eng |
| Dates: |
| Date | Event |
|---|
| 15 May 2023 | Published | | 22 March 2023 | Accepted |
|
| Publisher License: |
Creative Commons: Attribution 4.0 |
| Projects: |
|
| PubMed ID: |
37197377 |
| Web of Science ID: |
WOS:000987726300001 |
 |
Go to PubMed abstract |
| URI: |
https://openaccess.sgul.ac.uk/id/eprint/116184 |
| Publisher's version: |
https://doi.org/10.1093/rap/rkad039 |
Statistics
Item downloaded times since 23 Feb 2024.
Actions (login required)
 |
Edit Item |
